Personalis (PSNL) Income from Continuing Operations (2018 - 2026)
Personalis (PSNL) posted quarterly Income from Continuing Operations of 30032000.0 for Q1 2026, down 90.68% year-over-year from 322209809.26 in Q1 2025, and down 25.9% quarter-over-quarter from 23854000.0 in Q4 2025.
Personalis (PSNL) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Personalis' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 30032000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 90.68% year-over-year to 30032000.0; the TTM figure through Mar 2026 stood at 95594000.0 (down 42.72% YoY), while the FY2025 annual figure was 81312000.0, down 26.65% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 30032000.0, down from 23854000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 80303000.0 in Q4 2023, with the low at 39089000.0 in Q3 2024.
- The 5-year median for Income from Continuing Operations is 23955000.0 (2023), against an average of 17076411.76.
- The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations surged 358.22% in 2023, then plunged 3719.73% in 2025.
- Personalis' Income from Continuing Operations stood at 31099000.0 in 2022, then jumped by 358.22% to 80303000.0 in 2023, then tumbled by 99.18% to 659000.0 in 2024, then slumped by 3719.73% to 23854000.0 in 2025, then slipped by 25.9% to 30032000.0 in 2026.
- Business Quant data shows PSNL's Income from Continuing Operations at 30032000.0 in Q1 2026, 23854000.0 in Q4 2025, and 21652000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Personalis | 1.78 Bn | 1.56 Bn | 4.74 Mn | -31.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.68 Mn |
| Mar 31, 2026 | -30.03 Mn |
| Dec 31, 2025 | -6.79 Mn |
| Sep 30, 2025 | -21.65 Mn |
| Jun 30, 2025 | -20.06 Mn |
| Mar 31, 2025 | -15.75 Mn |
| Dec 31, 2024 | 613,000.00 |
| Sep 30, 2024 | -39.09 Mn |
| Jun 30, 2024 | -12.80 Mn |
| Mar 31, 2024 | -12.97 Mn |
| Dec 31, 2023 | -26.58 Mn |
| Sep 30, 2023 | -29.10 Mn |
| Jun 30, 2023 | -23.96 Mn |
| Mar 31, 2023 | -28.66 Mn |
| Dec 31, 2022 | -31.38 Mn |
| Sep 30, 2022 | -26.49 Mn |
| Jun 30, 2022 | -27.55 Mn |
| Mar 31, 2022 | -28.21 Mn |
| Dec 31, 2021 | -20.43 Mn |
| Sep 30, 2021 | -17.67 Mn |